HyQure BioTech is a specialized biosafety CRO supporting biologics and advanced therapies from early development through IND/CTA, BLA and commercialization.
We provide integrated biosafety testing and regulatory-oriented study support, including Viral Clearance Studies, Cell Line Characterization, adventitious agent testing, culture-based RCL/rcAAV testing, GMP-compliant NGS and Sanger sequencing, as well as method development, qualification and validation.
With strong scientific expertise and a focus on regulatory compliance, HyQure helps biopharmaceutical companies generate reliable biosafety data and study reports to support global regulatory submissions.